ArticleAsian journal of pharmaceutical sciences2021

A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens.

Minghui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.